We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Diagnostic Accuracy Demonstrated in Oral Glucose Tolerance Test

By LabMedica International staff writers
Posted on 02 Jan 2019
Print article
Image: During the oral glucose tolerance test (OGTT) blood glucose is tested two hours after drinking 75 grams of glucose, but a test one hour afterwards may be sufficient to diagnose diabetes (Photo courtesy of the US National Institutes of Health).
Image: During the oral glucose tolerance test (OGTT) blood glucose is tested two hours after drinking 75 grams of glucose, but a test one hour afterwards may be sufficient to diagnose diabetes (Photo courtesy of the US National Institutes of Health).
The incidence of overweight and obesity among children has increased dramatically in recent decades, with about one-third of children in the USA currently being either overweight or obese. Being overweight in early childhood increases risk for later obesity.

During an oral glucose tolerance test (OGTT), morphological features of the glucose curve, monophasic curve, glucose peak more than 30 minutes and 1‐hr glucose of equal to or greater than 155mg/dL, maybe associated with higher prediabetes risk, but their reproducibility and predictive ability in adolescents with obesity are unknown.

Scientists working with the Essentia Health-Duluth Clinic (Duluth, MN, USA) analyzed data from adolescent girls with obesity but without diabetes who underwent a multiple-sample OGTT at baseline (n = 93), six weeks (n = 83) and one year (n = 72) as part of a randomized controlled trial. They obtained plasma samples to measure glucose and insulin concentrations at 0, 30, 60, 90 and 120 minutes. Prediabetes was defined as a fasting glucose level between 100mg/dL and 126 mg/dL and/or a 2-hour glucose level between 140 mg/dL and 200 mg/dL. They compared short-term reproducibility (baseline to six weeks) and predictive ability for prediabetes (baseline to one year) for each feature using standard fasting and 2-hour OGTT criteria.

The percentage of youths with prediabetes (12%) was the same at baseline and at six weeks. Six girls diagnosed with prediabetes at baseline were reclassified as having normal glucose tolerance at six weeks, whereas eight girls with normal glucose tolerance at baseline were reclassified as having prediabetes at six weeks. Among 72 girls examined at 1-year follow-up, 11 had prediabetes at baseline and seven had prediabetes at one year. Compared with OGTT criteria, ROC-AUC was lower for monophasic curve variable (0.42), but not different for 1-hour glucose (0.67), glucose peak at 30 minutes (0.68) or a combination of 1-hour glucose and glucose peak variables (0.77).

Kannan Kasturi, MD, a pediatric endocrinologist and lead author of the study, said, “In up to 25% of youth who develop type 2 diabetes, the fasting, two-hour glucose concentration of HbA1c may be below the prediabetes diagnostic thresholds two years prior to diabetes diagnosis. The need to improve risk stratification is further amplified in adolescent girls who have high rates of developing type 2 diabetes and may benefit from targeted, intensive intervention programs.” The study was published on December 6, 2018, in the journal Pediatric Diabetes.

Related Links:
Essentia Health-Duluth Clinic

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.